GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (FRA:GEM) » Definitions » Ending Cash Position

GeNeuro (FRA:GEM) Ending Cash Position : €1.83 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is GeNeuro Ending Cash Position?

GeNeuro's Ending Cash Position for the quarter that ended in Dec. 2023 was €1.83 Mil.

GeNeuro's quarterly Ending Cash Position increased from Dec. 2022 (€5.59 Mil) to Jun. 2023 (€7.40 Mil) but then declined from Jun. 2023 (€7.40 Mil) to Dec. 2023 (€1.83 Mil).

GeNeuro's annual Ending Cash Position increased from Dec. 2021 (€5.48 Mil) to Dec. 2022 (€5.59 Mil) but then declined from Dec. 2022 (€5.59 Mil) to Dec. 2023 (€1.83 Mil).

GeNeuro Ending Cash Position Historical Data

The historical data trend for GeNeuro's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeNeuro Ending Cash Position Chart

GeNeuro Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.93 6.84 5.48 5.59 1.83

GeNeuro Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.48 11.00 5.59 7.40 1.83

GeNeuro Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

GeNeuro's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=5.593+-3.766
=1.83

GeNeuro's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=7.398+-5.571
=1.83

GeNeuro Ending Cash Position Related Terms

Thank you for viewing the detailed overview of GeNeuro's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

GeNeuro Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (FRA:GEM) » Definitions » Ending Cash Position
Comparable Companies
XPAR:ALMDP XPAR:ALBPS XPAR:ALTHX XPAR:ALINT XPAR:ALNEV XPAR:ALTME XPAR:ALOPM XPAR:ALTAO XPAR:ALVET XPAR:ALVIO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
Website
https://www.geneuro.com
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).